Treatment of polycystic ovary syndrome with Chinese drug longdan xiegan tang
Wang, D.Z.; Wang, Z.Q.; Shi, L.Y.
Journal of Traditional Chinese Medicine 8(2): 117-119
1988
ISSN/ISBN: 0255-2922 PMID: 3412006 Document Number: 308999
Document emailed within 1 workday
Related Documents
Zhang, N.; Xie, M. 2006: The nephrotoxicity in rats caused by Longdan Xiegan decoction Zhongguo Zhong Yao Za Zhi 31(10): 836-839Cheung, L.P.; Ma, R.C.W.; Lam, P.M.; Lok, I.H.; Haines, C.J.; So, W.Y.; Tong, P.C.Y.; Cockram, C.S.; Chow, C.C.; Goggins, W.B. 2008: Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Human Reproduction 23(6): 1431-1438
Luo, J.P.; Lou, Z.C. 1987: Morphological and histological studies of the Chinese drug longdan, radix Gentianae Yao Xue Xue Bao 22(8): 619-636
Shi, Y.; Feng, H.-j.; Liu, H.-r.; Zhu, D. 2009: Observation on therapeutic effect of acupuncture combined with chinese herbs on polycystic ovary syndrome of kidney deficiency and phlegm stasis type Zhongguo Zhen Jiu 29(2): 99-102
Bell, D.S.H. 2007: Treatment of infertility in the polycystic ovary syndrome New England Journal of Medicine 356(19): 1999-2000; Author Reply 2000-2001
Gandar, R.; Spizzo, M.; Collin, D. 1999: Diagnosis and treatment of polycystic ovary syndrome Journal de Gynecologie Obstetrique et Biologie de la Reproduction 28(6): 510-518
Starup, J. 1976: Treatment of patients with polycystic ovary syndrome. Ii Ugeskrift for Laeger 138(46): 2863-2866
Starup, J. 1976: Treatment of patients with polycystic ovary syndrome. i Ugeskrift for Laeger 138(46): 2866-2870
Barbieri, R.L.; Gargiulo, A.R. 2004: Metformin for the treatment of the polycystic ovary syndrome Minerva Ginecologica 56(1): 63-79
Gomel, V. 2003: Reasons for surgical treatment of polycystic ovary syndrome Journal de Gynecologie Obstetrique et Biologie de la Reproduction 32(3 Part 2): S46-S49
Teede, H.J.; Meyer, C.; Norman, R.J. 2005: Insulin-sensitisers in the treatment of polycystic ovary syndrome Expert Opinion on PharmacoTherapy 6(14): 2419-2427
Petrányi, G. 2005: Treatment experience with metformin in polycystic ovary syndrome Orvosi Hetilap 146(21): 1151-1155
Anwary, S.A.; Alfazzaman, M.; Bari, N.; Islam, M.R. 2012: Outcome of metformin treatment in polycystic ovary syndrome Mymensingh Medical Journal: Mmj 21(1): 60-65
Olszanecka-Glinianowicz, M.; Zahorska-Markiewicz, B.; Jochemczyk-Banek, U.; Banaś, M.ł; Zurakowski, A. 2004: Sibutramine administration in polycystic ovary syndrome treatment Ginekologia Polska 75(6): 470-474
Blum, I.; Kaufman, H.; Marilus, R.; Rusecki, Y.; Chovers, I. 1981: Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine Obstetrics and Gynecology 57(5): 661-665
Wang, H.-S. 2006: The role of metformin in the treatment of polycystic ovary syndrome (PCOS) Chang Gung Medical Journal 29(5): 445-447
Kachalina, T.S.; Dobrotina, A.F. 1988: Reproductive function following the surgical treatment of polycystic ovary syndrome Akusherstvo i Ginekologiia 5: 62-63
Sayin, N.Cenk.; Gücer, F.; Balkanli-Kaplan, P.; Yüce, M.Ali.; Ciftci, Sürk.; Kücük, M.; Yardim, T. 2003: Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome Journal of Reproductive Medicine 48(3): 165-170
Presl, J. 1984: The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome Ceskoslovenska Gynekologie 49(2): 124-125
Spritzer, P.M.; Motta, A.B. 2015: Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment International Journal of Clinical Practice 69(11): 1236-1246